Opiod row: Aveo Pharma says drug cleared by state authorities; govt says not approved
tapentadol and carisoprodol drugs is not approved in India, and prohibited production and export of such medicines, amid reports that an Indian company has been exporting the unlicensed combination.
Trump-Modi Meet
The mega MIGA, MAGA plans of India's Modi and US' Trump
Trump says India has more tariffs than others
Trump's 'golden rule' for imposing reciprocal tariffs
Mumbai-based Aveo Pharmaceuticals, however, claimed the combination is approved by the relevant state drug authorities and is exported under necessary approval from the assistant drug controllers with an export license issued by the central drug regulatory authority.
Aveo also claimed it is not the only company in India manufacturing a similar combination product.
A recent BBC investigation report alleged that the «unlicensed addictive» combination was being illegally exported to African nations such as Ghana and Nigeria, leading to a serious public health crisis of opioid addiction.
Denying the claims, Aveo told ET that the allegations are «entirely baseless» and «without merit.»
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrows Innovations
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
By — Metla Sudha Sekhar, IT Specialist and Developer
Marketing
Performance Marketing for eCommerce Brands
By — Zafer
